
Mesenchymal stem cells: From bench to bedside
Author(s) -
Teng Ma
Publication year - 2010
Publication title -
world journal of stem cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.907
H-Index - 18
ISSN - 1948-0210
DOI - 10.4252/wjsc.v2.i2.13
Subject(s) - mesenchymal stem cell , bench to bedside , regenerative medicine , medicine , clinical trial , cell therapy , stem cell , stem cell therapy , bioinformatics , neuroscience , intensive care medicine , pathology , medical physics , biology , microbiology and biotechnology
Human mesenchymal stem cells (hMSCs) have tremendous promise for use in a variety of clinical applications. The ability of these cells to self-renew and differentiate into multiple tissues makes them an attractive cell source for a new generation of cell-based regenerative therapies. Encouraging results from clinical trials have also generated growing enthusiasm regarding MSC therapy and related treatment, but gaps remain in understanding MSC tissue repair mechanisms and in clinical strategies for efficient cell delivery and consistent therapeutic outcomes. For these reasons, discoveries from basic research and their implementation in clinical trials are essential to advance MSC therapy from the laboratory bench to the patient's bedside.